Balversa and Eczema exacerbated - a phase IV clinical study of FDA data

Summary:

Eczema exacerbated is reported as a side effect among people who take Balversa (erdafitinib), especially for people who are female, 60+ old, also take Imodium, and have Diarrhea.

The phase IV clinical study analyzes which people have Eczema exacerbated when taking Balversa. It is created by eHealthMe based on reports of 485 people who have side effects when taking Balversa from the FDA, and is updated regularly.

What is Balversa?

Balversa has active ingredients of erdafitinib. eHealthMe is studying from 485 Balversa users. Check the latest studies of Balversa.

What is Eczema exacerbated?

Eczema exacerbated is found to be associated with 1,251 drugs and 531 conditions by eHealthMe. Check the latest studies of Eczema exacerbated.

On Jul, 05, 2026

485 people reported to have side effects when taking Balversa.
Among them, 11 people (2.27%) have Eczema exacerbated.

Could Balversa cause Eczema exacerbated?

Among these 11 people:

What is the gender of people who have Eczema exacerbated when taking Balversa? *

female: 100 %
male: 0.0 %

What is the age of people who have Eczema exacerbated when taking Balversa? *

What are other drugs people take besides Balversa? *

Imodium: 11 people, 100.00%
Pregabalin: 5 people, 45.45%
Prednisone: 5 people, 45.45%
Paclitaxel: 5 people, 45.45%
Gabapentin: 5 people, 45.45%
Duloxetine Hydrochloride: 5 people, 45.45%
Hydromorphone Hydrochloride: 4 people, 36.36%

What are other side effects people have besides Eczema exacerbated? *

Nail Discoloration: 11 people, 100.00%
Urinary Tract Infection: 11 people, 100.00%
Arthritis Bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection): 11 people, 100.00%
Cellulitis (infection under the skin): 11 people, 100.00%
Diarrhea: 11 people, 100.00%
Dizziness: 11 people, 100.00%
Dry Mouth: 11 people, 100.00%
Fatigue (feeling of tiredness): 11 people, 100.00%
Hair Growth Abnormal: 11 people, 100.00%
Nail Abnormalities (abnormal nail): 11 people, 100.00%

What are the existing conditions these people have? *

Urethral Cancer: 11 people, 100.00%
Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 11 people, 100.00%
Swelling: 11 people, 100.00%
Neuropathy Peripheral (surface nerve damage): 11 people, 100.00%
Diarrhea: 11 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Balversa and have Eczema exacerbated?

- Check whether Eczema exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Balversa:

Balversa (485 reports)

Browse all side effects of Balversa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eczema exacerbated:

Eczema exacerbated (1,251 drugs)

Browse all the conditions that are associated with Eczema exacerbated:

Eczema exacerbated (531 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on erdafitinib (the active ingredients of Balversa) and Balversa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.